OBJECTIVE
We aimed to explore the associations between type 2 diabetes onset age and cardiovascular disease (CVD) and all-cause mortality in the Chinese population.
RESEARCH DESIGN AND METHODS
This study included 101,080 participants free of prevalent diabetes and CVD at baseline from the Kailuan Study. All participants were monitored biennially until 31 December 2017. During follow-up, 11,384 participants were diagnosed as having type 2 diabetes. For each case subject, one control subject was randomly selected, matched for age (± 1 years) and sex. The final analysis comprised 10,777 case-control pairs. Weighted Cox regression models were used to evaluate the average hazard ratios (AHRs) and 95% CIs of incident CVD and all-cause mortality among patients with new-onset type 2 diabetes versus control subjects across age-groups.
Results
During a median follow-up of 5.57 years, 1,794 incident events (907 CVD events, of which there were 725 strokes and 887 deaths) occurred. After adjustment for potential confounders, participants with type 2 diabetes diagnosed at age <45 years had the highest relative risks of CVD and all-cause mortality relative to the matched control subjects, with AHRs of 3.21 (95% CI 1.18–8.72) for CVD, 2.99 (95% CI 1.01–9.17) for stroke, and 4.79 (95% CI 1.95–11.76) for all-cause mortality. The risks gradually attenuated with each decade increase in type 2 diabetes onset age.
CONCLUSIONS
The relative risks of CVD and all-cause mortality differed across type 2 diabetes onset age-groups, and the associations were more evident in younger-onset type 2 diabetes.
<b>Objective</b><b></b>
<p>We
aimed to explore the associations between type 2 diabetes onset age and cardiovascular
disease (CVD) and all-cause mortality in Chinese population.</p>
<p><b>Research design and methods</b></p>
<p>This study included 101,080 participants free of prevalent
diabetes and CVD at baseline from the Kailuan study. All participants were
followed biennially until December 31, 2017. A total of 11,384 participants
were diagnosed as type 2 diabetes during follow-up. For each case, one control
was randomly selected matched for age (±1 years) and sex. The final analysis
comprised 10,777 case-control pairs. Weighted Cox regression models were used
to evaluate the average hazard ratios (AHRs) and 95% confidence intervals (CIs)
of incident CVD and all-cause mortality among patients with new-onset type 2
diabetes <i>versus </i>controls across age
groups.</p>
<p><b>Results</b><b></b></p>
<p>During a median follow-up
of 5.57 years, 1794 incident events (907 CVD events, of which were 725 strokes,
and 887 deaths) occurred. After adjustment for potential confounders, participants
with type 2
diabetes diagnosed at age < 45 years had the highest risks of CVD and
all-cause mortality relative to the matched controls, with AHRs of 3.21 (95% CI
1.18–8.72) for CVD, 2.99 (95% CI 1.01–9.17) for stroke, and 4.79 (95% CI
1.95–11.76) for all-cause mortality. The risks gradually attenuated with each
decade increase in type 2 diabetes onset age. </p>
<p><b>Conclusions</b><b></b></p>
<p>The relative risks of CVD
and all-cause mortality differed across type 2 diabetes onset age groups, and
the associations were more evident in younger-onset type 2 diabetes. </p>
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.